Fig. 2From: Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonatesMean percent changes from baseline in lumbar spine and hip BMDs. Naive group: treatment-naïve group; switch group: transitioning from bisphosphonate group; BMD: bone mineral density; FN: femoral neck; TH: total hip. P values from Mann-Whitney U tests, for the mean percent change from baseline in the naive group versus the switch group. n.s denotes no significant difference between the valuesBack to article page